97 related articles for article (PubMed ID: 17693606)
1. The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis.
Jenne DE; Aries PM; Einwächter S; Akkad AD; Wieczorek S; Lamprecht P; Gross WL
Ann Rheum Dis; 2007 Sep; 66(9):1266-7. PubMed ID: 17693606
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
[TBL] [Abstract][Full Text] [Related]
3. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
Mukhtyar C; Luqmani R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
[TBL] [Abstract][Full Text] [Related]
4. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
[TBL] [Abstract][Full Text] [Related]
5. On the genetic contribution to selected multifactorial diseases with autoimmune characteristics.
Miterski B; Epplen JT; Gencik M
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):331-41. PubMed ID: 12030439
[TBL] [Abstract][Full Text] [Related]
6. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients.
Wieczorek S; Hoffjan S; Chan A; Rey L; Harper L; Fricke H; Holle JU; Gross WL; Epplen JT; Lamprecht P
Genes Immun; 2009 Sep; 10(6):591-5. PubMed ID: 19536154
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis.
Mascher B; Schmitt W; Csernok E; Tatsis E; Reil A; Gross WL; Seyfarth M
Exp Clin Immunogenet; 1997; 14(3):226-33. PubMed ID: 9493791
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis.
Muraközy G; Gaede KI; Ruprecht B; Gutzeit O; Schürmann M; Schnabel A; Schlaak M; Gross WL; Müller-Quernheim J
J Mol Med (Berl); 2001 Nov; 79(11):665-70. PubMed ID: 11715070
[TBL] [Abstract][Full Text] [Related]
9. Wegener's granulomatosis.
Lamprecht P; Gross WL
Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
[TBL] [Abstract][Full Text] [Related]
10. TNFRSF1A coding variants in multiple sclerosis.
Goris A; Fockaert N; Cosemans L; Clysters K; Nagels G; Boonen S; Thijs V; Robberecht W; Dubois B
J Neuroimmunol; 2011 Jun; 235(1-2):110-2. PubMed ID: 21565411
[TBL] [Abstract][Full Text] [Related]
11. Th1 and Th2 CD4+ T cells and Tc1 and Tc2 CD8+ T cells of patients with Wegener's granulomatosis.
Ohta N; Fukase S; Fuse T; Aoyagi M
J Laryngol Otol; 2002 Aug; 116(8):605-9. PubMed ID: 12389688
[TBL] [Abstract][Full Text] [Related]
12. Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis.
Blaschek A; Lohse P; Huss K; Borggraefe I; Mueller-Felber W; Heinen F; Hohlfeld R; Kümpfel T
Mult Scler; 2010 Dec; 16(12):1517-20. PubMed ID: 20876156
[TBL] [Abstract][Full Text] [Related]
13. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
14. TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina.
Kauffman MA; Gonzalez-Morón D; Garcea O; Villa AM
Mol Biol Rep; 2012 Jan; 39(1):117-21. PubMed ID: 21567205
[TBL] [Abstract][Full Text] [Related]
15. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.
Spriewald BM; Witzke O; Wassmuth R; Wenzel RR; Arnold ML; Philipp T; Kalden JR
Ann Rheum Dis; 2005 Mar; 64(3):457-61. PubMed ID: 15708894
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome.
Wieczorek S; Holle JU; Epplen JT
Curr Opin Rheumatol; 2010 Jan; 22(1):8-14. PubMed ID: 19864953
[TBL] [Abstract][Full Text] [Related]
17. [Antibody against intra-cytoplasmic antigens: marker of Wegener's granulomatosis?].
Gross WL; Lehmann H; Beigel A; Duncker A
Dtsch Med Wochenschr; 1986 Sep; 111(39):1499-500. PubMed ID: 3463499
[No Abstract] [Full Text] [Related]
18. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease.
Amoura Z; Dodé C; Hue S; Caillat-Zucman S; Bahram S; Delpech M; Grateau G; Wechsler B; Piette JC
Arthritis Rheum; 2005 Feb; 52(2):608-11. PubMed ID: 15692984
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.
Kümpfel T; Hohlfeld R
Nat Rev Neurol; 2009 Oct; 5(10):528-9. PubMed ID: 19794511
[TBL] [Abstract][Full Text] [Related]
20. Cerebral demyelination in Wegener's granulomatosis.
Brinar VV; Cikes N; Petelin Z; Hlavati M; Poser CM
Clin Neurol Neurosurg; 2004 Jun; 106(3):233-6. PubMed ID: 15177774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]